Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...

AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) has been approved by the US Food and Drug ...

British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab ...

AstraZeneca announced on Monday that it has secured approval from the US Food and Drug Administration, alongside Daiichi ...

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ...

The approval was based on results from the TROPION-Breast01 Phase III trial.

Discover why Merck presents a compelling long-term investment opportunity with its discounted valuation, robust pipeline, and ...

(Alliance News) - AstraZeneca PLC on Monday said Datroway has been approved in the US for patients with a type of breast cancer. The Cambridge-based pharmaceuticals firm explained the final approval ...

The past few years have been a roller coaster ride for M&A in pharma and biotech. After the highs of the pandemic came ...

Ritholtz Wealth Management lifted its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 6.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund ...

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight analysts that are presently covering the stock, Ratings reports. One ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...